|
|
| (18 intermediate revisions by one other user not shown) |
| Line 1: |
Line 1: |
| '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | | __NOTOC__'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' |
|
| |
|
| {{Occupational asthma}} | | {{Occupational asthma}} |
| {{CMG}}; {{AOEIC}} {{LG}} | | {{CMG}}; {{AOEIC}} {{LG}} |
|
| |
|
| |
|
| ==[[Occupational asthma overview|Overview]]== | | ==[[Occupational asthma overview|Overview]]== |
| Line 23: |
Line 22: |
| ==[[Occupational asthma screening|Screening]]== | | ==[[Occupational asthma screening|Screening]]== |
|
| |
|
| ==[[Occupational asthma natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | | ==[[Occupational asthma natural history, complications and prognosis|Natural History, Complications, and Prognosis]]== |
|
| |
|
| ==Diagnosis== | | ==Diagnosis== |
|
| |
|
| [[Occupational asthma diagnostic criteria|Diagnostic Criteria]] | [[Occupational asthma history and symptoms|History and Symptoms]] | [[Occupational asthma physical examination|Physical Examination]] | [[Occupational asthma laboratory findings|Laboratory Findings]] | [[Occupational asthma electrocardiogram|EKG]] | [[Occupational asthma chest x ray|Chest X ray]] | [[Occupational asthma CT|CT]] | [[Occupational asthma MRI|MRI]] | [[Occupational asthma echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Occupational asthma other imaging findings|Other Imaging Findings]] | [[Occupational asthma other diagnostic studies|Other Diagnostic Studies]]
| | [[Occupational asthma history and symptoms|History and Symptoms]] | [[Occupational asthma physical examination|Physical Examination]] | [[Occupational asthma laboratory findings|Laboratory Findings]] | [[Occupational asthma electrocardiogram|EKG]] | [[Occupational asthma chest x ray|Chest X ray]] | [[Occupational asthma other diagnostic studies|Other Diagnostic Studies]] |
|
| |
|
| ==Treatment== | | ==Treatment== |
| Line 35: |
Line 34: |
| ==Case Studies== | | ==Case Studies== |
| [[Occupational asthma case study one|Case #1]] | | [[Occupational asthma case study one|Case #1]] |
|
| |
|
| |
| ==Pathophysiology==
| |
| *Occupational asthma is characterized by variable airflow limitation and/or [[bronchial hyperresponsiveness|airway hyper-responsiveness]] due to causes and conditions attributable to a particular occupational environment and not [[Asthma pathophysiology#Stimuli or Triggering Factors|stimuli]] encountered outside the workplace.<ref name="AJRCCM">[http://ajrccm.atsjournals.org/cgi/content/full/167/3/450/ American Journal of Respiratory and Critical Care Medicine.] Vol 167. pp. 450-471, (2003). Proceedings of the First Jack Pepys Occupational Asthma Symposium.</ref><ref name="pmid18779187">Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D et al. (2008) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=18779187 Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement.] ''Chest'' 134 (3 Suppl):1S-41S. [http://dx.doi.org/10.1378/chest.08-0201 DOI:10.1378/chest.08-0201] PMID: [http://pubmed.gov/18779187 18779187]</ref>
| |
|
| |
| *Occupational asthma is the result of multiple genetic, environmental, and behavioral influences.
| |
|
| |
| :*The three main types of occupational asthma are:<ref name="pmid19281901">Maestrelli P, Boschetto P, Fabbri LM, Mapp CE (2009) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19281901 Mechanisms of occupational asthma.] ''J Allergy Clin Immunol'' 123 (3):531-42; quiz 543-4. [http://dx.doi.org/10.1016/j.jaci.2009.01.057 DOI:10.1016/j.jaci.2009.01.057] PMID: [http://pubmed.gov/19281901 19281901]</ref>
| |
| ::*Immunologically mediated with the involvement of specific [[IgE]],
| |
| ::*Immunologically mediated without the evidence of [[IgE]] involvement, and
| |
| ::*Non-immunologic, irritant mediated such as in [[reactive airways dysfunction syndrome]]
| |
|
| |
| :*Glutathione S-transferase (GSTP1 and GSTM1) and N-acetyltransferase (NAT1) genes that are involved in [[airway remodeling]], have shown to play are role in the pathogenesis of occupational asthma.<ref name="pmid11470996">Piirilä P, Wikman H, Luukkonen R, Kääriä K, Rosenberg C, Nordman H et al. (2001) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11470996 Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure.] ''Pharmacogenetics'' 11 (5):437-45. PMID: [http://pubmed.gov/11470996 11470996]</ref><ref name="pmid11994713">Mapp CE, Fryer AA, De Marzo N, Pozzato V, Padoan M, Boschetto P et al. (2002) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11994713 Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates.] ''J Allergy Clin Immunol'' 109 (5):867-72. PMID: [http://pubmed.gov/11994713 11994713]</ref>
| |
|
| |
| :*Skin exposure and inhalation of aero-allergens are the common modes of exposure in patients suffering from occupation asthma.<ref name="pmid18317018">Redlich CA, Herrick CA (2008) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=18317018 Lung/skin connections in occupational lung disease.] ''Curr Opin Allergy Clin Immunol'' 8 (2):115-9. [http://dx.doi.org/10.1097/ACI.0b013e3282f85a31 DOI:10.1097/ACI.0b013e3282f85a31] PMID: [http://pubmed.gov/18317018 18317018]</ref>
| |
|
| |
| *Certain high and low molecular weight occupational allergens such as animal proteins and platinum salts respectively, act as antigens and induce a antigen-specific [[IgE]] response that contributes to the immunologic pathogenesis.
| |
|
| |
| *Non-immunologic mechanisms that play a role in the pathogenesis include the direct inhibition of [[Beta-adrenergic agonist#β2 agonists|β2 agonist]] or elaboration of [[substance P]] by injured sensory nerves.
| |
|
| |
| ==Epidemiology and Demographics==
| |
| * [[Asthma]] affects as much as 15% of the Canadian population<ref>[http://chealth.canoe.ca/channel_section_details.asp?text_id=3370&channel_id=2014&relation_id=18604/ C-Health: Asthma in Canada(2007)]</ref> (and this is true of other [[developed countries]] too) and has increased four fold in the last 20 years. Various reasons can be identified for this increase that includes better diagnostic facilities along with a greater awareness regarding the disease have shown to play a major role. But, one cannot deny the part of increased [[environmental pollution]]. Researchers have been working on the relation between the environment and human health since long and the air we breathe is the primary cause for [[lung diseases]] like [[asthma]], [[rhinitis]], [[COPD]]s, etc. that affect us today.
| |
| * Approximately, '''10 to 15%''' of adult-onset asthma cases are affected by an aggravation of [[symptoms]] while at work and an improvement when away, which implies that they may be suffering from occupational asthma.<ref name="pmid19281900">Dykewicz MS (2009) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19281900 Occupational asthma: current concepts in pathogenesis, diagnosis, and management.] ''J Allergy Clin Immunol'' 123 (3):519-28; quiz 529-30. [http://dx.doi.org/10.1016/j.jaci.2009.01.061 DOI:10.1016/j.jaci.2009.01.061] PMID: [http://pubmed.gov/19281900 19281900]</ref><ref name="pmid19281901">Maestrelli P, Boschetto P, Fabbri LM, Mapp CE (2009) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19281901 Mechanisms of occupational asthma.] ''J Allergy Clin Immunol'' 123 (3):531-42; quiz 543-4. [http://dx.doi.org/10.1016/j.jaci.2009.01.057 DOI:10.1016/j.jaci.2009.01.057] PMID: [http://pubmed.gov/19281901 19281901]</ref> Thus, when an individual’s asthma is caused, not aggravated, by workplace materials, it is defined as occupational asthma ("OA"). In the USA, OA is considered the most common occupational lung disease<ref>http://www.lni.wa.gov/Safety/Research/files/AsthmaCme.pdf</ref>.
| |
| * At present, over 400 workplace substances have been identified as having asthmagenic or allergenic properties<ref>http://www.asmanet.com/asmapro/agents.htm</ref>. Their existence and magnitude vary from region to region and the type of [[industry]] and can be as varied as wood dust ([[cedar]], [[ebony]], etc.), persulfates (Hairsprays), [[zinc]] or even seafood like [[prawns]]. For example, in [[France]] the industries most affected in order of importance are Bakeries and cake-shops, [[automobile industry]] and hairdressers<ref>[http://oem.bmj.com/cgi/content/abstract/60/2/136/ Reported incidence of occupational asthma in France, 1996–99: the ONAP programme]. J Ameille, G Pauli, A Calastreng-Crinquand, D Vervloët, Y Iwatsubo, E Popin, M C Bayeux-Dunglas and M C Kopferschmitt-Kubler2 and the corresponding members of the ONAP</ref>, whereas in Canada the principle cause is wood dust, followed by [[isocyanates]].
| |
|
| |
| ==Diagnosis==
| |
| ===History and Symptoms===
| |
| *Less than five years of exposure to an occupational agent can be enough for the appearance of the first occupational asthma [[symptoms]]. This depends on whether the reason for the occupational asthma to occur was exposure to the causative agent over a period of time (with a latency period) or a single exposure to an irritant but at a very high concentration (without latency period). Both eventually result in OA.
| |
|
| |
| *[[Coughing]], [[wheezing]], nasal irritation, [[dyspnea|difficulty in breathing]], tightness of chest are the most common symptoms and can be recognized more easily by asking oneself the following questions:
| |
| #Are any of the above symptoms recurrent/chronic?
| |
| #Are they present at work?
| |
| #Do they worsen towards the end of the work day and/or end of the week?
| |
| #Does the employee/worker feel an improvement in his condition when away from work, on vacation or on weekends?
| |
|
| |
| *If these symptoms persist, the person is most likely suffering from occupational asthma. However, one must be aware that this could also be because the person is already suffering from asthma and his condition was simply aggravated by workplace irritants (Work-aggravated asthma). In this case, although he will suffer similar consequences as someone who is suffering from OA (loss of work, medical expenses, etc.), his disease cannot be considered as having an occupational origin.
| |
|
| |
| *Like for any other disease correct diagnosis is important. According to Dr. Susan Tarlo: <blockquote>“It is important to recognize, since if due to a workplace sensitizer and, if undetected and if the patient continues to work with even small exposure to the relevant sensitizing agent, the prognosis is worse”. She also concluded that, “the chance of eventual improvement in Asthma severity after stopping exposure decreases with the duration of exposure after the onset of the symptoms. The best chance of asthma clearing or significantly improving is associated with early diagnosis and early removal from ongoing exposure.”<ref>[http://www.oemac.org/oemac/en/files/OAdiagnosis%20OEMAC2003.pdf Diagnosis of Occupational Asthma] Tarlo S.</ref></blockquote>
| |
|
| |
| *The biggest challenge, clinically, is that family doctors and patients alike do not have sufficient information about occupational asthma. Only 15% of asthmatic patients are asked by their clinician if symptoms relate to work conditions.<ref name="EvidenceReport">[http://www.ahrq.gov/downloads/pub/evidence/pdf/asthmawork/asthwork.pdf Diagnosis and Management of Work-Related Asthma.] Evidence Report/Technology Assessment number 129. Beach J, Rowe B, Blitz S, Crumley E, Hooton N, Russell K, Spooner C</ref>. Patients often avoid mentioning work-related asthma triggers for fear of losing their jobs or simply because they are unaware of the association between working conditions and asthmatic symptom onset. Patients run the risk of irreversible damange. An incorrect diagnosis can result in considerable decrements in quality of life measures such as medical, social, and financial status.
| |
|
| |
| *Diagnosis of OA is complex and requires a period of time. First, the patient’s occupational and clinical history is taken and his symptoms are charted (Charting is usually done at the end of a typical work week and within 24 hours of the occurrence of symptoms in order to get objective information). Once this has been established, the following <b>diagnostic methods</b> are used:
| |
|
| |
| ===Non-specific bronchial hyperreactivity===
| |
| * A non-specific bronchial hyperreactivity test involves testing with methacoline, after which the Forced Expiratory Volume in 1 second (FEV<sup>1</sup>) of the patient is measured.
| |
| * This test is often used for measuring the intensity of a person's asthma and to confirm that the person needs to be treated for asthma. Other non specific tests could even require the patient to run in open air or on a treadmill for a few minutes at a continuous pace. In this case, the individual’s Peak Expiratory Flow Rate (PEFR) is measured. (The peak expiratory flow rate measures how fast a person can exhale) <ref>[http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9408523 Risk and incidence of asthma attributable to occupational exposure among HMO members.] Milton DK, Solomon GM, Rosiello RA, Herrick RF. Am J Ind Med 1998;33:1–10.</ref>.
| |
|
| |
| ===Skin prick tests===
| |
| * A skin prick test is performed on the inner aspect of the forearm. A technician will draw a grid and systematically drop specific allergens within grid spaces. The skin is then pricked through a lancet to induce a potential interaction.
| |
| * Reactions, if any, occur within 10-15 minutes of allergen contact. The results of these reactions assist in determination of level of severity of allergic reaction and types of allergic triggers.<ref>http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9333767 Kroczyńska-Bednarek J, Grzelewska-Rzymowska I, Tymińska K.</ref>
| |
|
| |
| ===IgE-specific tests===
| |
| * Immunoglobulin E is an antibody that is effective against toxins. Since it can also trigger allergic reactions to specific [[allergens]] like [[pollen]], the IgE test is performed to evaluate whether the subject is allergic to these substances<ref>[http://www.allergysa.org/appen9.htm Allergy Society of South Africa.] The Skin Prick Test. Toerien A,Potter P C, Buys C</ref>.
| |
|
| |
| ===Spirometric tests===
| |
| * Conventionally, a [[spirometer]] is a device used to measure timed expired and inspired volumes.
| |
| * Expired and inspired volume measurements then enable us to measure how quickly the lungs can be emptied and filled and whether it is effective.
| |
| * These measurements need to be stated at body temperature and the pressure will have to be saturated with water vapor to get the correct values. The specificity of measurement is important as if the spirometer is dry, the recorded volume of air displaced is lower than that actually displaced by the lungs<ref>http://researchnews.osu.edu/archive/hayfcare.htm</ref>.
| |
|
| |
| ===Peak Expiratory Flow at work===
| |
| * This test uses the peak expiratory flow at rest (PEFR) method. The primary difference from the at-rest test is that at work testing measures the functioning of the patient's airways at his place of work and not necessarily in a controlled environment. The patient breathes into a Peak Expiratory Flow monitor (a hand-held device that has a mouth piece at one end and a scale with an indicator on the other).<ref>http://www.nationalasthma.org.au/html/management/spiro_book/sp_bk002.asp</ref>
| |
|
| |
| ===[[Specific inhalation challenge]]===
| |
| <ul> <li><b>Realistic method</b></li>
| |
| “The Realistic Method” is a whole body sealed chamber where the patient is exposed to articles that are present in their workplace. This method has the advantage of being able to assess, albeit highly subjectively, ocular and nasal symptoms as well as a reduction in FEV<sup>1</sup>.
| |
|
| |
| <li><b>Closed-circuit method</b></li>
| |
| This test requires the patient to breathe [[aerosols]] of the suspected ‘asthmagens’ through an oro-facial mask. These ‘asthmagens’ are aerosolized using closed circuit chambers, and the quantities and concentrations administered being minute and extremely stable minimize the risk of exaggerated responses.
| |
| </ul>
| |
|
| |
| *Of the above methods of doing a diagnosis, procedures such as monitoring of [[spirometry]] or [[peak expiratory flow]] at work and Specific Inhalation Challenges (SIC) have been proved as the most objective and reliable methods.
| |
|
| |
| ==Treatment==
| |
| *According to the [[Canadian Centre for Occupational Health and Safety]] (CCOHS), better education of workers, management, unions and medical professionals is the key to the prevention of OA. This will enable them to identify the risk factors and put in place preventive measures like masks or exposure limits, etc.
| |
| * Recovery is directly dependent on the duration and level of exposure to the causative agent. Depending on the severity of the case, the condition of the patient can improve dramatically during the first year after removal from exposure.
| |
| *Three basic types of procedures are used for treating the affected workers<ref name="EvidenceReport"/>:
| |
| ====1) Reducing exposure====
| |
| * This method is most effective for those affected by irritant-induced OA.
| |
| * Thus, by reducing their exposure duration and level to the causative agent, the probability of suffering another reaction is lowered. But exposure can be reduced in other ways like making use of face masks or providing better ventilation.
| |
| * Now, more and more di-isocyanate free spray paints are available.
| |
| * Similarly, most hospitals and healthcare companies have exchanged latex gloves for other materials. Thus, reducing exposure to known asthmagens can also be used as a preventive measure.
| |
|
| |
| ====2) Removal from exposure====
| |
| * Persons affected by OA that occurred after a latency period, whether a few months or years, must be immediately removed from exposure to the causative agent. This is their only chance of recovery.
| |
| * This entails severe socio-economic consequences for the worker as well as the employer due to loss of job, unemployment, compensation issues, quasi-permanent medical expenditures, hiring and re-training of new personnel, etc.
| |
| * According to recent research, the probability that those who suffer from OA remain unemployed longer than those who suffer from non-occupational asthma is higher. One solution to this problem is relocating the employee in the same company away from the causative agents.
| |
|
| |
| ====3) Medical and pharmacological treatment====
| |
| * Anyone diagnosed with asthma will have to undergo medical treatment.
| |
| * This is complementary to either removing or reducing the patient’s exposure to the causal agents.
| |
| * Two types of medication can be used:
| |
|
| |
| <ul>
| |
| <li><b>Relievers or bronchodilators</b></li>
| |
| {{main|Bronchodilator}}
| |
| Short-acting [[beta-agonist]]s like [[salbutamol]] or [[terbutaline]] or long-acting beta-agonists like [[salmeterol]] and [[formoterol]] or [[anticholinergic]], etc. dilate airways which relieve the symptoms thus reducing the severity of the reaction. Some patients also use it just before work to avoid a drop in the FEV<sup>1</sup>.
| |
|
| |
| <li><b>Preventers</b></li>
| |
| Anti-inflammatory agents like [[corticosteroid]]s, LKTRA or mast cell stabilizers can be used depending on the severity of the case.
| |
| </ul>
| |
|
| |
| ==Compensation issues==
| |
| * When a person is diagnosed as having occupational asthma, it can result in serious socio-economic consequences not only for the workers but also for the employer and the healthcare system. The employee has to be taken off job immediately to prevent any further damage to his health. And, the probability of being re-employed is lower for those suffering from OA as compared to those suffering from normal asthma. The employer not only pays compensation to the employee, but will also have to spend a considerable amount of time and energy and funds for hiring and training new personnel. <ref>http://www.nlm.nih.gov/medlineplus/ency/article/003443.htm</ref><ref>[http://www.erj.ersjournals.com/cgi/content/abstract/7/5/969/ Medicolegal and compensation aspects of occupational asthma.] Dewitte JD, Chan-Yeung M, Malo J-L.</ref>
| |
|
| |
|
| ==Related Chapters== | | ==Related Chapters== |
| Line 144: |
Line 40: |
| *[[Specific inhalation challenge]] | | *[[Specific inhalation challenge]] |
|
| |
|
| ==References==
| |
| {{reflist|2}}
| |
|
| |
|
| [[Category:Disease]]
| |
| [[Category:Pulmonology]] | | [[Category:Pulmonology]] |
| [[Category:Asthma]]
| |
| [[Category:Occupational safety and health]]
| |
| [[Category:Up-To-Date]]
| |
| [[Category:Up-To-Date pulmonology]]
| |
|
| |
|
| {{WikiDoc Help Menu}} | | {{WikiDoc Help Menu}} |
| {{WikiDoc Sources}} | | {{WikiDoc Sources}} |